Signaturefd, LLC Bei Gene, Ltd. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Signaturefd, LLC holds 9 shares of BGNE stock, worth $1,712. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 800.0%

Holding current value

$1,712

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$143.93 - $224.51 $1,151 - $1,796	8 Added 800.0%	9 $2,000
Q2 2024 Jul 29, 2024	SELL	$129.52 - $174.32 $1,165 - $1,568	-9 Reduced 90.0%	1 $0
Q1 2024 May 03, 2024	BUY	$141.8 - $181.47 $425 - $544	3 Added 42.86%	10 $1,000
Q2 2023 Aug 01, 2023	SELL	$178.3 - $266.78 $356 - $533	-2 Reduced 22.22%	7 $1,000
Q4 2022 Jan 27, 2023	SELL	$125.51 - $229.3 $2,384 - $4,356	-19 Reduced 67.86%	9 $1,000
Q3 2022 Nov 08, 2022	SELL	$131.8 - $202.24 $263 - $404	-2 Reduced 6.67%	28 $4,000
Q2 2022 Aug 10, 2022	BUY	$121.11 - $216.05 $1,211 - $2,160	10 Added 50.0%	30 $5,000
Q1 2022 May 02, 2022	SELL	$146.52 - $269.56 $68,864 - $126,693	-470 Reduced 95.92%	20 $4,000
Q4 2021 Jan 25, 2022	SELL	$248.56 - $389.34 $16,902 - $26,475	-68 Reduced 12.19%	490 $133,000
Q3 2021 Oct 28, 2021	SELL	$249.6 - $403.14 $19,219 - $31,041	-77 Reduced 12.13%	558 $203,000
Q2 2021 Jul 26, 2021	BUY	$292.75 - $367.01 $60,892 - $76,338	208 Added 48.71%	635 $218,000
Q1 2021 Apr 30, 2021	BUY	$260.64 - $382.12 $46,393 - $68,017	178 Added 71.49%	427 $149,000
Q4 2020 Feb 11, 2021	BUY	$221.31 - $316.61 $26,114 - $37,359	118 Added 90.08%	249 $64,000
Q3 2020 Nov 03, 2020	BUY	$189.18 - $286.44 $11,918 - $18,045	63 Added 92.65%	131 $38,000
Q2 2020 Jul 30, 2020	BUY	$123.9 - $195.41 $7,434 - $11,724	60 Added 750.0%	68 $13,000
Q1 2020 Apr 23, 2020	BUY	$121.84 - $173.19 $974 - $1,385	8 New	8 $1,000
Q3 2019 Oct 16, 2019	SELL	$120.61 - $148.29 $964 - $1,186	-8 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$113.99 - $146.86 $911 - $1,174	8 New	8 $1,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account